When your most cancers has progressed immediately after prior treatment method with selected hormone therapies, enzalutamide or abirateroneSymptoms of minimal blood cell counts are popular during treatment method with LYNPARZA, but can be a sign of significant bone marrow problems, which includes MDS or AML.are breastfeeding or intend to breastfeed